Analysis of HLA class I and II alleles regarding to lymph node and distant metastasis in patients with non-small cell lung cancer

Lung Cancer

Volumn 66, Issue 2, 2009, Pages 231-236

  Bulut, Ismet ^a   Meral, Mehmet ^a   Kaynar, Hasan ^a   Pirim, Ibrahim ^a   Bilici, Mehmet ^a   Gorguner, Metin ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Distant metastasis; Frequency; Healthy controls; HLA antigens; Lung cancer; Lymph node metastasis

Indexed keywords

HLA A2 ANTIGEN; HLA A26 ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B35 ANTIGEN; HLA B44 ANTIGEN; HLA B60 ANTIGEN; HLA CW1 ANTIGEN; HLA CW4 ANTIGEN; HLA CW5 ANTIGEN; HLA CW6 ANTIGEN; HLA CW7 ANTIGEN; HLA DQ02 ANTIGEN; HLA DQ07 ANTIGEN; HLA DQ6 ANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ANTIGEN EXPRESSION; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE FREQUENCY; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; IMMUNOGENETICS; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

AGED; ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 70350338775     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.01.012     Document Type: Article

References (32)

1. Henderson B.E., Ross R.K., and Pike M.C. Toward the primary prevention of cancer. Science 254 (1991) 1131-1138
2. Gunen H., Kizkin O., Tahaoglu C., et al. Utility of blind forceps biopsy of the main carina and upper-lobe carina in patients with non-small cell lung cancer. Chest 119 (2001) 632-637
3. Smith M.E., Marsh S.G., Bodmer J.G., et al. Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc Natl Acad Sci USA 86 (1989) 5557-5561
4. Bodmer W.F., Browning M.J., Krausa P., et al. Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann N Y Acad Sci 690 (1993) 42-49
5. Cormier J.N., Hijazi Y.M., Abati A., et al. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo. Int J Cancer 75 (1998) 517-524
6. Cromme F.V., van Bommel P.F., Walboomers J.M., et al. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br J Cancer 69 (1994) 1176-1181
7. Iaffaioli R.V., Maio M., Ruggiero G., et al. HLA and prognostic factors in primary breast cancer. Int J Cancer 35 (1985) 581-585
8. Wank R., and Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352 (1991) 723-725
9. Chan S.H., Simons M.J., and Oon C.J. HLA antigen in Chinese patients with hepatocellular carcinomas. J Natl Cancer Inst 65 (1980) 21-23
10. Rogentine G.N., Dellon A.L., and Chretein P.B. Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5. Cancer 39 (1977) 2345-2347
11. Terasaki P., Perdue S.T., and Mikey M.R. HLA frequencies in cancer: a second study. In: Mulvihill J.J., Miller R.W., and Fraumeni J.F. (Eds). Genetics of human cancer (1977), Raven, New York 321-328
12. Prazak J., Mericka O., and Chytry J. Histocompatibility locus antigens (HLA) in the epidermoid type of lung carcinoma. J Cancer Res Clin Oncol 116 (1990) 525-527
13. Romano P.J., Bartholomew M., Smith P.J., et al. HLA antigens influence resistance to lung carcinoma. Hum Immunol 31 (1991) 236-240
14. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
15. Silvestri G.A., Tanoue L.T., Margolis M.L., et al. American College of Chest Physicians. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 123 1 Suppl. (2003) 147-156
16. Tokumoto H. Analysis of HLA-DRB1-related alleles in Japanese patients with lung cancer-relationship to genetic susceptibility and resistance to lung cancer. J Cancer Res Clin Oncol 124 (1998) 511-516
17. So T., Takenoyama M., Sugaya M., et al. Unfavorable prognosis of patients with non-small cell lung carcinoma associated with HLA-A2. Lung Cancer 32 (2001) 39-46
18. Yoshimura C., Nomura S., Kanazawa S., et al. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2. J Cancer Res Clin Oncol 128 (2002) 581-588
19. Nakamura H., Kawasaki N., Hagiwara M., et al. Cellular immunologic parameters related to age, gender, and stage in lung cancer patients. Lung Cancer 28 (2000) 139-145
20. Ogoshi K., Tajima T., Mitomi T., et al. HLA antigens are candidate markers for prediction of lymph node metastasis in gastric cancer. Clin Exp Metastasis 14 (1996) 277-281
21. Ogoshi K., Tajima T., Mitomi T., et al. HLA-A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer. Cancer Immunol Immunother 45 (1997) 53-59
22. Dellon A.L., Rogentine Jr. G.N., and Cheretein P.B. Prolonged survival in bronchogenic carcinoma associated with HLA-A antigens W-19 and HLA-B5: a preliminary report. J Natl Cancer Inst 54 (1975) 1283-1286
23. Mottironi V.D., Banks S.M., Pollara B., et al. HLA and survival in lung cancer. Clin Immunol Immunopathol 45 (1987) 55-62
24. Prazak J., and Mericka O. HLA antigens and bronchogenic carcinoma. Neoplasma 36 (1989) 599-602
25. Nakamura H., Saji H., Ogata A., et al. Immunologic parameters as significant prognostic factors in lung cancer. Lung Cancer 37 (2002) 161-169
26. Wang H.Y., Zhou J., Zhu K., et al. Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis. J Exp Med 195 (2002) 1397-1406
27. Takasugi M., Terasaki P.I., Henderson B., et al. HL-A antigens in solid tumors. Cancer Res 33 (1973) 648-650
28. Sengar D.P., McLeish W.A., Stewart T.H., et al. HLA antigens in bronchogenic carcinoma. Oncology 34 (1977) 143-145
29. Markman M., Braine H.G., and Abeloff M.D. Histocompatibility antigens in small cell carcinoma of the lung. Cancer 54 (1984) 2943-2945
30. Yoshimura C., Nomura S., Yamaoka M., et al. Analysis of serum ErbB-2 protein and HLA-DRB1 in Japanese patients with lung cancer. Cancer Lett 152 (2000) 87-95
31. Sastre-Garau X., Loste M.N., Vincent-Salomon A., et al. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix. Int J Cancer 69 (1996) 159-164
32. Coleman N., and Stanley M.A. Characterization and functional analysis of the expression of vascular adhesion molecules in human papillomavirus-related disease of the cervix. Cancer 74 (1994) 884-892